Tag: Charles River Laboratories
Charles River, Related Sciences team up for AI-driven drug discovery
Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences have announced a multi-program collaboration valued at an undisclosed amount to deploy Logica, an AI-powered ... Read More
Immutep taps Charles River for IMP761 LAG-3 antibody preclinical study
Immutep Limited, an Australian biotech company specializing in LAG-3 immunotherapies for cancer and autoimmune diseases, has partnered with Charles River Laboratories to conduct a GLP ... Read More
Pisgah Ridge Solar project : Duke Energy begins operations at Navarro County facility
Duke Energy has commenced operations at the 250MW Pisgah Ridge Solar project in Navarro County, Texas, which is the American energy company’s largest solar power ... Read More
Arlington Capital Partners acquires AVS Bio from Charles River Laboratories
Arlington Capital Partners, a US-based private equity firm, has acquired Avian Vaccine Services business from Charles River Laboratories. The terms of the transaction were not ... Read More
Pisgah Ridge Solar project : Duke Energy breaks ground on 250MW solar power plant
Duke Energy Sustainable Solutions, a commercial brand of Duke Energy, has broken ground on the 250MW Pisgah Ridge Solar project in Texas. Once operational, the ... Read More
Charles River Laboratories to acquire gene therapy CDMO Vigene Biosciences
Charles River Laboratories International has signed an all-cash deal worth $292.5 million to acquire Vigene Biosciences, a US-based gene therapy contract development and manufacturing organization ... Read More
HemaCare to be acquired by Charles River Laboratories for $380m
Charles River acquisition of HemaCare : Charles River Laboratories International, an early-stage contract research organization, has agreed to acquire HemaCare for about $380 million in ... Read More
Charles River to acquire MPI Research for $800m
Pharma acquisition news: US-based Charles River Laboratories International has agreed to acquire non-clinical contract research organization (CRO) MPI Research for about $800 million. Based in ... Read More